发明名称 UN NUOVO BIOMARCATORE PER LA DIAGNOSI PRECOCE E L'IMMUNOTERAPIA DEL CANCRO
摘要 <p>This invention refers to DNA and RNA molecules that encode fusion polypeptides containing or derived from the amino acid sequence called EASI- PRO which contains the sequence RTNKEASI. More specifically, the invention involves products of nucleic acids and polypeptides obtained as a result of alternative splicing mechanisms and compositions containing all or part of the EASI -PRO sequence. In addition, the invention refers to antibodies and oligonucleotides as tools for the detection of new markers to be used in the molecular diagnostics of cancer. Finally, the invention refers to anti-cancer vaccines based on the protein containing the EASI -PRO sequence and on the nucleic acid molecules described above, and to therapeutic antibodies and drugs intended to inhibit the function of this protein.</p>
申请公布号 ITRM20100256(A1) 申请公布日期 2011.11.20
申请号 IT2010RM00256 申请日期 2010.05.19
申请人 FARMAFIN SPA 发明人 AURISICCHIO LUIGI;CILIBERTO GENNARO
分类号 主分类号
代理机构 代理人
主权项
地址